Clinical Trial Update: Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of MP-424 combined with Interferon Beta and Ribavirin in treatment-naïve or interferon-experienced patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon-beta (interferon beta)
• MP-424
• Ribavirin (ribavirin)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Chronic Hepatitis C(CHC) | Phase 3 | Status: COMPLETED | Results posted: 2018-10-26